Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AC141272.1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | ZNF32 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | MRGPRG | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | NRDE2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ARVCF | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | MAP1S | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | NFYA | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | PLRG1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | CECR2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | FHDC1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |